Research Paper Volume 12, Issue 15 pp 15682—15704

Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson’s disease patients with type 2 diabetes mellitus

Figure 2. Comparison of UPDRS score (A) and the percentage of patients with fibrinogen>4 (mmol/L), LDL<2 (mmol/L), SAE, brain infarctions (B) and WMLs with Fazekas scale scores (C) among PDD, DMD and PD-DMD patients. PD - patients with Parkinson’s disease without type 2 diabetes mellitus; DM - type 2 diabetes mellitus without Parkinson’s disease; PD-DM - patients with Parkinson’s disease and type 2 diabetes mellitus; PDD - patients with Parkinson’s disease with dementia; DMD - type 2 diabetes mellitus with dementia; PD-DMD - patients with Parkinson’s disease and type 2 diabetes mellitus and dementia; D(-) - without dementia; D(+) - with dementia; UPDRS - Unified Parkinson’s Disease Rating Scale; NMSS - nonmotor symptoms scale for Parkinson’s Disease; LDL-C - low-density lipoprotein cholesterol; SAE - subcortical arteriosclerotic encephalopathy; WMLs - white matter lesions; NS - not significant. *p<0.05, **p<0.01, ***p<0.001.